Highlights 2cureX AB

Equities

2CUREX

SE0010468124

Market Closed - Nasdaq Stockholm Other stock markets 06:25:32 2024-04-29 am EDT			5-day change	1st Jan Change
0.364 ^SEK	-18.39%		-7.85%	-81.89%

Feb. 29	2curex AB Elects Grith Hagel as a New Board Member	CI
Feb. 22	2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
2cureX AB Receives Ethical Approval for HIPEC Clinical Trial	Dec. 06	CI
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 23	CI
2cureX Announces to Focus All Resources on Making IndiTreat Testing Available at Hospitals Worldwide by Accelerating the Development of an Automated IVD System	23-10-26	CI
2cureX Signs Contract with Notified Body in EU for Certification of Cancer Tests	23-10-11	MT
2curex Launches Its First Two IndiTreat® Products Ce-Marked Under the New Ivd Regulation	23-08-30	CI
2cureX AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
2cureX AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-25	CI
2cureX Announces Launch of Updated Specimen Collection Set	23-03-23	CI
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-23	CI
2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
2CureX and Pedoc Medical Sign Distribution Agreement	22-12-20	CI
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-24	CI
2cureX AB Announces Distribution Agreement with Werfen	22-09-19	CI
2cureX AB Signs IndiTreat Distribution Agreement for Romania with Onco Systems S.r.l	22-09-01	CI
2cureX AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-25	CI
2Curex AB and Gamidor Diagnostics Ltd. Enters into Distribution Agreement of IndiTreat® to Israel	22-06-28	CI
2Curex Has Signs A Distribution Agreement with Algol Diagnostics Oy	22-05-31	CI
2cureX AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights 2cureX AB

Equities

2CUREX

SE0010468124

Highlights

Filters